UB Paderborn / Katalog / Suche / in CDI

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

The lancet oncology, 2021-04, Vol.22 (4), p.450-462

2021

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial

Journal of clinical oncology, 2020-08, Vol.38 (22), p.2476-2487

2020

Link zum Volltext

Verfügbarkeit prüfen

Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers

The journal of clinical endocrinology and metabolism, 2019-05, Vol.104 (5), p.1417-1428

2019

Link zum Volltext

Verfügbarkeit prüfen

Oncology for the rhinologist

Current opinion in otolaryngology & head and neck surgery, 2024-02, Vol.32 (1), p.14

2024

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2020-03, Vol.106 (3), p.564-570

2020

Link zum Volltext

Verfügbarkeit prüfen

Amidst the excitement: A cautionary tale of immunotherapy, pseudoprogression and head and neck squamous cell carcinoma

Oral oncology, 2016-11, Vol.62, p.147-148

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine‐refractory thyroid cancer

Cancer, 2017-11, Vol.123 (21), p.4114-4121

2017

Link zum Volltext

Verfügbarkeit prüfen

Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer

CA: a cancer journal for clinicians, 2023-03, Vol.73 (2), p.164-197

2023

Link zum Volltext

Verfügbarkeit prüfen

A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer

Oral oncology, 2024-07, Vol.154, p.106861, Article 106861

2024

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus‐associated oropharyngeal squamous cell cancer

Head & neck, 2018-02, Vol.40 (2), p.233-241

2018

Link zum Volltext

Verfügbarkeit prüfen

Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques

JAMA oncology, 2017-11, Vol.3 (11), p.1487

2017

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial

Nature medicine, 2023-12, Vol.29 (12), p.3077-3089

2023

Link zum Volltext

Verfügbarkeit prüfen

Salvage surgery for recurrent larynx cancer

Head & neck, 2019-11, Vol.41 (11), p.3906-3915

2019

Link zum Volltext

Verfügbarkeit prüfen

Isoprene and monoterpene emissions from alder, aspen and spruce short-rotation forest plantations in the United Kingdom

Biogeosciences, 2021-04, Vol.18 (8), p.2487-2510

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer

Cancer, 2019-09, Vol.125 (17), p.2984-2990

2019

Link zum Volltext

Verfügbarkeit prüfen

Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers

Oral oncology, 2020-05, Vol.104, p.104641-104641, Article 104641

2020

Link zum Volltext

Verfügbarkeit prüfen

Organ preservation for patients with anterior mucosal squamous cell carcinoma of the nasal cavity: Rhinectomy‐free survival in those refusing surgery

Head & neck, 2019-08, Vol.41 (8), p.2741-2747

2019

Link zum Volltext

Verfügbarkeit prüfen

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy

JAMA network open, 2021-06, Vol.4 (6), p.e2113205-e2113205

2021

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy Mythbusters in Head and Neck Cancer: The Abscopal Effect and Pseudoprogression

American Society of Clinical Oncology educational book, 2019-05 (39), p.352-363

2019

Link zum Volltext

Verfügbarkeit prüfen

Introducing Checkpoint Inhibitors Into the Curative Setting of Head and Neck Cancers: Lessons Learned, Future Considerations

American Society of Clinical Oncology educational book, 2022-04, Vol.42 (42), p.1-526

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial

Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers

Oncology for the rhinologist

Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing

A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma

Amidst the excitement: A cautionary tale of immunotherapy, pseudoprogression and head and neck squamous cell carcinoma

Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine‐refractory thyroid cancer

Outcomes and toxicities of definitive radiotherapy and reirradiation using 3‐dimensional conformal or intensity‐modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies

Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer

A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer

Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus‐associated oropharyngeal squamous cell cancer

Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques

Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial

Salvage surgery for recurrent larynx cancer

Hypoxia-Directed Treatment of Human Papillomavirus-Related Oropharyngeal Carcinoma

Isoprene and monoterpene emissions from alder, aspen and spruce short-rotation forest plantations in the United Kingdom

The 3 Bs of cancer care amid the COVID‐19 pandemic crisis: “Be safe, be smart, be kind”—A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancer

Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer

Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers

Organ preservation for patients with anterior mucosal squamous cell carcinoma of the nasal cavity: Rhinectomy‐free survival in those refusing surgery

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy

Immunotherapy Mythbusters in Head and Neck Cancer: The Abscopal Effect and Pseudoprogression

Introducing Checkpoint Inhibitors Into the Curative Setting of Head and Neck Cancers: Lessons Learned, Future Considerations

Suchergebnisse filtern